13 completed. 13 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 13 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Avian Influenza: new trials by email Literature Review of Avian Influenza trials Research Report on Avian Influenza
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 2017 A/H7N9 IIV Revaccination A/H7N9, AS03, Phosphate Buffered Saline (PBS) diluent - Avian Influenza, Influenza Immunisation | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 304 | 2018-12-18 | 2021-07-30 |
| Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza A/H7N9, MF59, Phosphate Buffered Saline (PBS) diluent - Avian Influenza, Influenza Immunisation | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 372 | 2018-11-02 | 2021-05-17 |
| 2013/2017 H7N9 Prime-Boost Interval A/H7N9, AS03, Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013 - Avian Influenza, Influenza Immunisation | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 180 | 2018-08-21 | 2021-08-02 |
| Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 AS03, Inactivated influenza H7N9 vaccine, Influenza Virus Quadrivalent Inactivated Vaccine - Avian Influenza, Influenza | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 149 | 2018-02-20 | 2020-08-06 |
| Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly AS03, Inactivated influenza H7N9 vaccine, Phosphate Buffered Saline (PBS) diluent - Avian Influenza, Influenza Immunisation | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 720 | 2018-02-14 | 2024-09-19 |
| A Safety and Immunogenicity Study of IVACFLU-A/H5N1 IVACFLU-A/H5N1 vaccine, Placebo - Avian Influenza | Phase 2 / Phase 3 | Completed | Institute of Vaccines and Medical Biologicals, Vietnam | 930 | 2017-03-07 | 2019-05-21 |
| H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses AS03, Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203, Monovalent influenza A/H7N9 virus vaccine - Avian Influenza, H1N1 Influenza | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2016-11-07 | 2024-10-09 |
| H7N9 Mix and Match With MF59 in Healthy Elderly Persons MF59, Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013 - Avian Influenza | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 479 | 2014-10-01 | 2017-07-06 |
| Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine OrniFlu® inactivated vaccine - Avian Influenza | Phase 2 | Completed | Mahidol University | 60 | 2014-06-01 | 2015-04-09 |
| Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults Influenza vaccine (whole virion, Vero cell derived) - Influenza, Avian Influenza | Phase 1 / Phase 2 | Completed | Alachua Government Services, Inc. | 231 | 2009-05-01 | 2015-10-09 |
| Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine H5N1 influenza vaccine - Avian Influenza | Phase 2 | Completed | Novartis Vaccines | 47 | 2007-10-01 | 2016-12-01 |
| Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects MF59-eH5N1, eTIV_a, MF59-eH5N1 + eTIV_a - Pandemic, Avian Influenza | Phase 2 | Completed | Novartis | 405 | 2007-04-01 | 2014-02-03 |
| High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza Oseltamivir - Influenza, Avian Influenza | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 326 | 2006-02-01 | 2014-06-06 |
Influenza in Birds (13) · Influenza, Human (10) · Dyspnea (1) · Orthomyxoviridae Infections (1)
Animal Diseases (13) · Bird Diseases (13) · Infections (13) · RNA Virus Infections (13) · Virus Diseases (13) · Orthomyxoviridae Infections (12) · Respiratory Tract Diseases (10) · Respiratory Tract Infections (10) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
Influenza Vaccines (4) · MF59 oil emulsion (2) · Oseltamivir (1)
National Institute of Allergy and Infectious Diseases (NIAID) (8) · Alachua Government Services, Inc. (1) · Institute of Vaccines and Medical Biologicals, Vietnam (1) · Mahidol University (1) · Novartis (1) · Novartis Vaccines (1)
United States (7) · Thailand (2) · Vietnam (2) · Austria (1) · Colombia (1) · Finland (1) · Italy (1) · Singapore (1)
Gerald Aichinger, MD (1) · Punnee Pitisuttithum (1) · Tawee Chotpitayasunohdh, MD (1) · Tran N Duong, MD, PhD (1) · Tran Tinh Hien, MD (1)
PMID 39756216, PMID 20810680, PMID 21606530, PMID 23536690, PMID 23723457, PMID 28533093, PMID 31812464, PMID 35465983, PMID 37466221, PMID 38537255, PMID 39798434, PMID 42630599